
GRDN Stock Forecast & Price Target
GRDN Analyst Ratings
Bulls say
Guardian Pharmacy Services Inc. is positioned favorably due to its robust technological capabilities, which are expected to enhance value-based care conversations and drive margin improvements through integration with recently acquired operations. The company's strong market share, alongside core trends in the pharmacy services sector, indicates an appealing earnings power potential, particularly from its newly acquired facilities. Additionally, the use of robotic dispensing technology, with approximately 80 machines currently in operation, has significantly improved accuracy and reduced the time to fill requests to less than one day, contributing to overall operational efficiency.
Bears say
Guardian Pharmacy Services Inc. faces a variety of significant risks that contribute to a negative outlook on its stock. These risks include potential changes in regulatory and reimbursement policies, challenges in managing relationships with long-term care facilities (LTCFs), and vulnerabilities related to supply chain disruptions. Furthermore, difficulties in hiring and retaining qualified clinical staff, sourcing and integrating acquisitions, and reliance on technology assets pose additional threats to the company’s operational stability and financial performance.
This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.
GRDN Analyst Forecast & Price Prediction
Start investing in GRDN
Order type
Buy in
Order amount
Est. shares
0 shares